SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Yellow Regulatory News (BYG)

Share Price Information for Big Yellow (BYG)

Share Price is delayed by 15 minutes
Get Live Data
862.50    27.50 (3.29%)
Bid:
856.50
Ask:
857.50
Spread: 1.00 (0.117%)
Market Cap: £1.69b
BYG Live PriceLast checked at - London Stock Exchange

Intraday Big Yellow Share Chart

Form 8.3

28 Nov 2025 09:23

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1.

KEY INFORMATION

 

 

 

(a)

Full name of discloser:

Massachusetts Financial Services Company

 

(b)

Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BIG YELLOW GROUP PLC

 

(d)

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e)

Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

27 November 2025

 

(f)

In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

 

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

 

Class of relevant security:

10p ordinary (GB0002869419)

 

 

Interests

Short Positions

 

 

Number

%

Number

%

 

(1)

Relevant securities owned and/or controlled:

4,294,140

2.18 %

 

 

 

(2)

Cash-settled derivatives:

 

 

 

 

 

(3)

Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

Total

4,294,140 *

2.18 %

 

 

 

* Massachusetts Financial Services Company and/or its affiliates do not have discretion regarding voting decisions in respect of 386,238 shares that are included in the total above.

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

 

 

 

 

(b)

Rights to subscribe for new securities (including directors’ and other employee options)

 

 

 

Class of relevant security in relation to which subscription right exists:

 

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

 

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

 

 

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

10p ordinary (GB0002869419)

Sale

3,254

11.5900 GBP

 

 

 

(b)

Cash-settled derivative transactions

 

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

(ii)

Exercise

 

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

 

 

Class of relevant security

Nature of dealing e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

 

4.

OTHER INFORMATION

 

 

 

(a)

Indemnity and other dealing arrangements

 

 

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

 

(c)

Attachments

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

 

Date of disclosure

28 November 2025

 

Contact name

Nikki Cagan

 

Telephone number

+442074297243

 

 

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251128137533/en/

Copyright Business Wire 2025

Date   Source Headline
31st Aug 20211:33 pmRNSDirector/PDMR Shareholding
31st Aug 202112:53 pmRNSTotal Voting Rights
26th Aug 20218:55 amRNSDirector Declaration
6th Aug 202110:55 amRNSDirector/PDMR Shareholding
3rd Aug 20214:47 pmRNSHolding(s) in Company
3rd Aug 20211:14 pmRNSDirector/PDMR Shareholding
30th Jul 202112:08 pmRNSTotal Voting Rights
22nd Jul 20214:34 pmRNSDirector/PDMR Shareholding
22nd Jul 20214:33 pmRNSDirector/PDMR Shareholding
22nd Jul 202111:58 amRNSResult of AGM
22nd Jul 20217:00 amRNSTrading Statement
20th Jul 202111:44 amRNSNotification of Q1 Trading Update
1st Jul 202111:21 amRNSAcquisition Completion
1st Jul 20219:00 amRNSTotal Voting Rights
30th Jun 202110:02 amRNSDirector/PDMR Shareholding
24th Jun 20217:00 amRNSResults of Placing
23rd Jun 20214:34 pmRNSProposed placing of new ordinary shares
21st Jun 202111:24 amRNSAnnual Report & AGM Notice 2021
1st Jun 20218:11 amRNSTotal Voting Rights
25th May 20217:00 amRNSFinal Results Year Ended 31 March 2021
6th May 20213:38 pmRNSTotal Voting Rights
28th Apr 20217:00 amRNSNotification of Full Year Results
27th Apr 20217:00 amRNSFreehold Acquisition
8th Apr 20217:00 amRNSNon-Executive Director Appointment
31st Mar 20219:16 amRNSNotification of Transactions of Directors/PDMR
31st Mar 20219:01 amRNSBlock Listing Return
31st Mar 20219:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSFreehold Acquisition
15th Mar 202112:53 pmRNSHolding(s) in Company
1st Mar 20219:50 amRNSDirector/PDMR Shareholding
26th Feb 20213:23 pmRNSDirector/PDMR Shareholding
26th Feb 20213:21 pmRNSTotal Voting Rights
16th Feb 202111:50 amRNSDirector/PDMR Shareholding
2nd Feb 20217:00 amRNSNon-Executive Director Appointment
29th Jan 202111:35 amRNSHolding(s) in Company
29th Jan 202110:24 amRNSTotal Voting Rights
18th Jan 20213:51 pmRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSDirectorate Change
13th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Results
31st Dec 20209:21 amRNSTotal Voting Rights
30th Nov 202010:55 amRNSTotal Voting Rights
17th Nov 20207:00 amRNSResults for the Six Months ended 30 September 2020
13th Nov 20202:28 pmRNSHolding(s) in Company
4th Nov 20207:00 amRNSNotification of Half Year Results
30th Oct 202011:55 amRNSTotal Voting Rights
5th Oct 20207:00 amRNSPlanning Update
30th Sep 202010:54 amRNSBlock Listing Return
30th Sep 202010:49 amRNSTotal Voting Rights
28th Sep 202012:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.